Lazard Asset Management’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $23.4M | Buy |
|
|||||
2025
Q1 | $21.5M | Sell |
|
|||||
2024
Q4 | $193M | Buy |
|
|||||
2024
Q3 | $251M | Buy |
|
|||||
2024
Q2 | $220M | Sell |
|
|||||
2024
Q1 | $534M | Buy |
|
|||||
2023
Q4 | $519M | Buy |
|
|||||
2023
Q3 | $302M | Buy |
|
|||||
2023
Q2 | $276M | Buy |
|
|||||
2023
Q1 | $240M | Buy |
|
|||||
2022
Q4 | $244M | Sell |
|
|||||
2022
Q3 | $266M | Buy |
|
|||||
2022
Q2 | $249M | Buy |
|
|||||
2022
Q1 | $240M | Sell |
|
|||||
2021
Q4 | $270M | Sell |
|
|||||
2021
Q3 | $244M | Sell |
|
|||||
2021
Q2 | $259M | Sell |
|
|||||
2021
Q1 | $237M | Sell |
|
|||||
2020
Q4 | $222M | Buy |
|
|||||
2020
Q3 | $126M | Buy |
|
|||||
2020
Q2 | $112M | Buy |
|
|||||
2020
Q1 | $74M | Sell |
|
|||||
2019
Q4 | $344M | Buy |
|
|||||
2019
Q3 | $255M | Buy |
|
|||||
2019
Q2 | $200M | Buy |
|
|||||
2019
Q1 | $188M | Buy |
|
|||||
2018
Q4 | $181M | Sell |
|
|||||
2018
Q3 | $218M | Buy |
|
|||||
2018
Q2 | $34.4M | Buy |
|
|||||
2018
Q1 | $16.5M | Sell |
|
|||||
2017
Q4 | $25.1M | Buy |
|
|||||
2017
Q3 | $27.4M | Buy |
|
|||||
2017
Q2 | $18.6M | Sell |
|
|||||
2017
Q1 | $18.4M | Sell |
|
|||||
2016
Q4 | $57.5M | Sell |
|
|||||
2016
Q3 | $289M | Sell |
|
|||||
2016
Q2 | $321M | Sell |
|
|||||
2016
Q1 | $394M | Sell |
|
|||||
2015
Q4 | $376M | Buy |
|
|||||
2015
Q3 | $335M | Buy |
|
|||||
2015
Q2 | $232M | Sell |
|
|||||
2015
Q1 | $234M | Sell |
|
|||||
2014
Q4 | $249M | Sell |
|
|||||
2014
Q3 | $277M | Sell |
|
|||||
2014
Q2 | $298M | Sell |
|
|||||
2014
Q1 | $534M | Sell |
|
|||||
2013
Q4 | $612M | Sell |
|
|||||
2013
Q3 | $521M | Sell |
|
|||||
2013
Q2 | $592M | Buy |
|